Table of Contents Table of Contents
Previous Page  302 / 398 Next Page
Information
Show Menu
Previous Page 302 / 398 Next Page
Page Background

297

Progression level of extracapsular spread and tumour

budding for cervical lymph node metastasis of oral

squamous cell carcinoma

S. Yamada

∗

, M. Otsuru, S. Yanamoto, T. Hasegawa,

H. Aizawa, T. Kamata, N. Yamakawa, T. Kohgo, A. Ito,

Y. Noda, C. Hirai, T. Kitamura, M. Okura, T. Kirita, M. Ueda,

T. Yamashita, Y. Ota, T. Komori, M. Umeda, H. Kurita

Department of Dentistry and Oral Surgery, Shinshu University

School of Medicine, Matsumoto, Japan

Background:

The extracapsular spread (ECS) of cervical lymph

node metastasis was identified as a strong prognostic factor in oral

squamous cell carcinoma (OSCC) patients at a high risk of recur-

rence. Tumour budding was reported to be correlated with poor

prognosis and lymph node metastasis including occult metastasis.

Objectives:

The aim of the present study was to investigate the

efficacy of tumour budding on the prognosis, and to analyse the

association between progression level of ECS and tumour buss-

ing in OSCC patients based on large number of patients with a

multicentre retrospective analysis.

Methods:

The Kaplan–Meier method was used to examine overall

survival (OS) and relapse-free survival (RFS) curves. Prognosis

factor for recurrence was analysed with univariate andmultivariate

analysis.

Findings:

ECS was detected in 216 cases and analysed. The five-

year overall survival and RFS rates of patients with Type C, which

was microscopically defined as tumour invasion to perinodal fat

or muscle tissue, were significantly poor at 40.6% and 37.8%,

respectively. The results of a univariate analysis suggested that

the prognosis of ECS in OSCC patients is associated with its pro-

gression level, particularly Type C. The five-year RFS rate of Type

C with tumour budding was significantly poor at 31.5%. Type C

with tumour budding correlated with local and regional recurrence

as well as distant metastasis. In a multivariate analysis, tumour

budding was identified as an independent prognostic factor.

Conclusion:

These results suggest that the progression level of

ECS and tumour budding are useful prognostic factors in OSCC

patients.

http://dx.doi.org/10.1016/j.ijom.2017.02.998

Maxillary ameloblastoma: factors associated with risk of

recurrence

R. Yang

∗

, Z.Q. Liu, C.B. Peng, W. Cao, T. Ji

Department of Oral and Maxillofacial – Head and Neck

Oncology, Ninth People’s Hospital, Shanghai Jiao Tong

University School of Medicine, China

Objective:

Maxillary ameloblastomas are rare and associatedwith

an aggressive course because of the anatomical composition of the

maxilla and adjacent structures. The risk factors associated with

recurrence were analysed in this retrospective study.

Subjects and Methods:

Cases of maxillary ameloblastoma

reported in a tertiary hospital from 2005 to 2015 were analysed

to identify clinicopathological and radiological factors associated

with recurrence using univariate and multivariate Cox regression

analyses.

Results:

A total of 890 patients with ameloblastomas were

treated in this study, of whom only 51 (5.7%) had maxillary

ameloblastomas. The median follow-up period was 56

±

28.65

months. Of the maxillary ameloblastomas, 29 (56.8%) were pri-

mary and 22 (43.1%) were recurrent. Soft tissue or maxillary sinus

invasion and primary or recurrent tumour status were risk factors

significantly associated with recurrence in the univariate analyses

(

P

= 0.006 versus

P

= 0.025, respectively), while the association

between recurrence and surgical methods was borderline signifi-

cant (

P

= 0.08). The multivariate Cox regression analysis showed

that soft tissue or maxillary sinus involvement was significantly

associated with recurrence (

P

= 0.023).

Conclusion:

Recurrent tumours and tumours with soft tissue

or maxillary sinus involvement were risk factors for recurrence

among maxillary ameloblastoma patients.

http://dx.doi.org/10.1016/j.ijom.2017.02.999

The effect and molecular mechanism of TSP-1 on biological

behaviour of mucoepidermoid cancer

S. Yang

∗

, L. Guo, P. Ji, J.L. Song, X.Y. Wang, X.F. Tang

Suining Central Hospital, China

Background:

Mucoepidermoid cancer (MEC) is one of the malig-

nant tumours of salivary gland. Some researches have proved that

function of TSP-1 on tumour only by inhibition of angiogenesis,

but had no effect on tumour cells.

Objectives:

This article explores the impact of TSP-1 on bio-

logical behaviour of MEC and provides some references on the

mechanisms of development and metastasis of MEC.

Methods:

Immunofluorescence (IFC) andWestern Blot were used

to detect expression of TSP-1, CD36 and CD47 of MEC to choose

the most suitable experimental object. MTT was used to detect

the effect of TSP-1 on proliferation of MEC. Transwell was per-

formed to investigate the ability change of invasion. Cell cycle

was evaluated by flow cytometry and IFC experiments.

Findings:

Poorly differentiated MEC which reduced expression

TSP-1 and the same time express CD36 and CD47 as experimental

object. Cell growth rate ability of TSP-1, CD36 and CD47 group is

obviously slower then the control. Transwell showed the number

of TSP-1 group cells dramatically decreased, there is no significant

differences between CD47 blocked and TSP-1 group. Early apop-

totic cell number of TSP-1 group was dramatically higher than the

CD47 blocked and control group, but no significant differences

with CD36 blocked.

Conclusions:

TSP-1 dramatically inhibit proliferation of MEC

by combining with CD36 not CD47. TSP-1 inhibits invasive abil-

ity of MEC, which is closely rated with CD36. TSP-1 is mainly

combined with CD47 to induce MEC apoptosis.

http://dx.doi.org/10.1016/j.ijom.2017.02.1000

Detection of genome mutations in high risk oral pre-cancer

lesions

E.H. Yu

∗

, H.F. Tu

National Yang-Ming University Hospital, Yilan, Chinese Taipei

Background:

The progression of oral cancer includes a period

of pre-cancer lesion, or oral potentially malignant disorders

(OPMD). The malignant transformation rate of OPMD is about